# Silicon Laboratories Inc. (SLAB) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Technology / Semiconductors & Chip Equipment. Price $222.34, market value $7.4 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Silicon Laboratories Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.77**. A PEG of 0.77 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 8.7×**. Each dollar of revenue is priced at 8.7×.
- **Price / book: 6.8×**. The shares trade at 6.8× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -0.1%** (5-yr avg 0.5%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 60.6%**. Silicon Laboratories Inc. keeps 60.6% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -5.1%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -8.3%**. The company reported a net loss over the last twelve months.
- **Return on equity: -5.9%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -4.3%**. Return on all capital, debt included, is -4.3%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -3.1%**. Each dollar of assets produces -3.1% of profit.

## Growth
- **Revenue growth (1 yr): 34.3%** (3-yr -8.5%/yr, 5-yr 9.0%/yr). Revenue grew 34.3% over the last year, against 9.0% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 66.6%**. Earnings per share rose 66.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -16.9%/yr**. Free cash flow has compounded at -16.9% a year over three years.

## Financial health
- **Debt to equity: 0.07**. Debt is 0.07 times equity: a conservative balance sheet.
- **Current ratio: 4.69** (quick 4.69). Current assets cover the next year's liabilities 4.69 times.
- **Altman Z-score: 27.59**. A Z-score of 27.59 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Silicon Laboratories Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (7 analysts). 7 analysts cover Silicon Laboratories Inc.; the consensus is hold, with an average price target of $222.86 (+0% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 69.4%** (YTD 69.9%, 3-mo 1.9%). The shares are up 69.4% over twelve months including dividends.
- **From 52-week high: -0.5%** (92.5% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 58**. An RSI of 58 is neutral.
- **Beta (1 yr): 0.52** (volatility 53%). Beta of 0.52 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SLAB · Page: https://foliofundamentals.com/stocks/slab

Not investment advice.